BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ben-Shimol S, Greenberg D, Givon-Lavi N, Elias N, Glikman D, Rubinstein U, Dagan R; Israeli Bacteremia and Meningitis Active Surveillance Group. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel. Vaccine. 2012;30:6600-6607. [PMID: 22939907 DOI: 10.1016/j.vaccine.2012.08.012] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Ahn JG, Choi SY, Kim DS, Kim KH. Changes in pneumococcal nasopharyngeal colonization among children with respiratory tract infections before and after use of the two new extended-valency pneumococcal conjugated vaccines. Infect Dis (Lond) 2015;47:385-92. [PMID: 25712791 DOI: 10.3109/00365548.2014.1001997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
2 Berezin EN, Jarovsky D, Cardoso MRA, Mantese OC. Invasive pneumococcal disease among hospitalized children in Brazil before and after the introduction of a pneumococcal conjugate vaccine. Vaccine 2020;38:1740-5. [PMID: 31874778 DOI: 10.1016/j.vaccine.2019.12.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cohen R, Varon E, Béchet S, Bonacorsi S, Levy C. Comparative impact of pneumococcal conjugate vaccines on pneumococcal meningitis according to underlying conditions. Vaccine 2016;34:4850-6. [PMID: 27595445 DOI: 10.1016/j.vaccine.2016.08.069] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
4 Plosker GL. 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Infants, Children, and Adolescents. Pediatr Drugs 2013;15:403-23. [DOI: 10.1007/s40272-013-0047-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
5 Raman R, Brennan J, Ndi D, Sloan C, Markus TM, Schaffner W, Talbot HK. Marked Reduction of Socioeconomic and Racial Disparities in Invasive Pneumococcal Disease Associated With Conjugate Pneumococcal Vaccines. J Infect Dis 2021;223:1250-9. [PMID: 32780860 DOI: 10.1093/infdis/jiaa515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Somekh E, Aviner S, Miron D, Dagan R. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance. Vaccine 2014;32:3452-9. [PMID: 24690148 DOI: 10.1016/j.vaccine.2014.03.065] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 12.5] [Reference Citation Analysis]
7 Cho YC, Chiu NC, Lu CY, Huang DT, Huang FY, Chang LY, Huang LM, Chi H. Redistribution of Streptococcus pneumoniae Serotypes After Nationwide 13-valent Pneumococcal Conjugate Vaccine Program in Children in Northern Taiwan. Pediatr Infect Dis J 2017;36:e334-40. [PMID: 28650416 DOI: 10.1097/INF.0000000000001664] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
8 Lixandru RI, Falup-Pecurariu C, Bleotu L, Mercas A, Leibovitz E, Dagan R, Greenberg D, Falup-Pecurariu O. Streptococcus pneumoniae Serotypes and Antibiotic Susceptibility Patterns in Middle Ear Fluid Isolates During Acute Otitis Media and Nasopharyngeal Isolates During Community-acquired Alveolar Pneumonia in Central Romania. Pediatr Infect Dis J 2017;36:151-4. [PMID: 27798547 DOI: 10.1097/INF.0000000000001379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Flasche S, Ojal J, Le Polain de Waroux O, Otiende M, O'Brien KL, Kiti M, Nokes DJ, Edmunds WJ, Scott JAG. Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya. BMC Med 2017;15:113. [PMID: 28592303 DOI: 10.1186/s12916-017-0882-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
10 Weinberger DM, Givon-Lavi N, Shemer-Avni Y, Bar-Ziv J, Alonso WJ, Greenberg D, Dagan R. Influence of pneumococcal vaccines and respiratory syncytial virus on alveolar pneumonia, Israel. Emerg Infect Dis 2013;19:1084-91. [PMID: 23763864 DOI: 10.3201/eid1907.121625] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
11 Del Amo E, Esteva C, Hernandez-Bou S, Galles C, Navarro M, Sauca G, Diaz A, Gassiot P, Marti C, Larrosa N, Ciruela P, Jane M, Sá-Leão R, Muñoz-Almagro C; Catalan Study Group of Invasive Pneumococcal Disease. Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain. PLoS One 2016;11:e0151125. [PMID: 26953887 DOI: 10.1371/journal.pone.0151125] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
12 Dagan R, Ben-Shimol S, Benisty R, Regev-Yochay G, Lo SW, Bentley SD, Hawkins PA, McGee L, Ron M, Givon-Lavi N, Valinsky L, Rokney A. A Nationwide Outbreak of Invasive Pneumococcal Disease in Israel Caused by Streptococcus Pneumoniae Serotype 2. Clin Infect Dis 2020:ciaa1720. [PMID: 33197932 DOI: 10.1093/cid/ciaa1720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Givon-Lavi N, Ben-Shimol S, Cohen R, Greenberg D, Dagan R. Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations. Vaccine 2015;33:1934-40. [PMID: 25744226 DOI: 10.1016/j.vaccine.2015.02.062] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
14 Ben-Shimol S, Greenberg D, Hazan G, Shemer-Avni Y, Givon-Lavi N, Dagan R. Seasonality of both bacteremic and nonbacteremic pneumonia coincides with viral lower respiratory tract infections in early childhood, in contrast to nonpneumonia invasive pneumococcal disease, in the pre-pneumococcal conjugate vaccine era. Clin Infect Dis 2015;60:1384-7. [PMID: 25595749 DOI: 10.1093/cid/civ023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
15 Leibovitz E, David N, Ribitzky-Eisner H, Abo Madegam M, Abuabed S, Chodick G, Maimon M, Fruchtman Y. The Epidemiologic, Microbiologic and Clinical Picture of Bacteremia among Febrile Infants and Young Children Managed as Outpatients at the Emergency Room, before and after Initiation of the Routine Anti-Pneumococcal Immunization. Int J Environ Res Public Health 2016;13:E723. [PMID: 27447651 DOI: 10.3390/ijerph13070723] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 de Waure C, Specchia ML, Capizzi S, Aljicevic M, Dujovic M, Malaj A, Ricciardi W. Effectiveness of 7-valent pneumococcal conjugate vaccine: A meta-analysis of post-marketing studies. World J Meta-Anal 2015; 3(3): 151-162 [DOI: 10.13105/wjma.v3.i3.151] [Reference Citation Analysis]
17 Glikman D, Dagan R, Barkai G, Averbuch D, Guri A, Givon-Lavi N, Ben-Shimol S; Israel Bacteremia and Meningitis Active Surveillance Group. Dynamics of Severe and Non-severe Invasive Pneumococcal Disease in Young Children in Israel Following PCV7/PCV13 Introduction. Pediatr Infect Dis J 2018;37:1048-53. [PMID: 29750768 DOI: 10.1097/INF.0000000000002100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
18 Rodrigo C, Lim WS. The Relevance of Pneumococcal Serotypes. Curr Infect Dis Rep 2014;16. [DOI: 10.1007/s11908-014-0403-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
19 Ben-shimol S, Greenberg D, Hazan G, Givon-lavi N, Gottesman G, Grisaru-soen G, Dagan R. Differential Impact of Pneumococcal Conjugate Vaccines on Bacteremic Pneumonia Versus Other Invasive Pneumococcal Disease. Pediatric Infectious Disease Journal 2015;34:409-16. [DOI: 10.1097/inf.0000000000000604] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
20 Regev-Yochay G, Chowers M, Chazan B, Gonzalez E, Gray S, Zhang Z, Pride M. Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel. Hum Vaccin Immunother 2018;14:2527-32. [PMID: 30188760 DOI: 10.1080/21645515.2018.1475811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Licciardi PV, Russell FM, Balloch A, Burton RL, Nahm MH, Gilbert G, Tang ML, Mulholland EK. Impaired serotype-specific immune function following pneumococcal vaccination in infants with prior carriage. Vaccine 2014;32:2321-7. [PMID: 24613524 DOI: 10.1016/j.vaccine.2014.02.064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
22 Danino D, Givon-Lavi N, Ben-Shimol S, Greenberg D, Dagan R. Understanding the Evolution of Antibiotic-nonsusceptible Pneumococcal Nasopharyngeal Colonization Following Pneumococcal Conjugate Vaccine Implementation in Young Children. Clin Infect Dis 2019;69:648-56. [PMID: 30371763 DOI: 10.1093/cid/ciy926] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
23 Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis 2014;59:1724-32. [PMID: 25159581 DOI: 10.1093/cid/ciu683] [Cited by in Crossref: 123] [Cited by in F6Publishing: 104] [Article Influence: 15.4] [Reference Citation Analysis]
24 Weinberger DM, Pitzer VE, Regev-Yochay G, Givon-Lavi N, Dagan R. Association Between the Decline in Pneumococcal Disease in Unimmunized Adults and Vaccine-Derived Protection Against Colonization in Toddlers and Preschool-Aged Children. Am J Epidemiol 2019;188:160-8. [PMID: 30462150 DOI: 10.1093/aje/kwy219] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
25 Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR; Serotype Replacement Study Group. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013;10:e1001517. [PMID: 24086113 DOI: 10.1371/journal.pmed.1001517] [Cited by in Crossref: 324] [Cited by in F6Publishing: 293] [Article Influence: 36.0] [Reference Citation Analysis]
26 Lu CY, Huang LM. Is Pneumococcal Serotype Replacement Impending? Pediatr Neonatol 2016;57:363-4. [PMID: 27641269 DOI: 10.1016/j.pedneo.2015.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
27 Regev-Yochay G, Reisenberg K, Katzir M, Wiener-Well Y, Rahav G, Strahilevitz J, Istomin V, Tsyba E, Peretz A, Khakshoor S, Dagan R; Israeli Adult Invasive Pneumococcal Disease Group. Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009-June 20151. Emerg Infect Dis 2018;24:1275-84. [PMID: 29912694 DOI: 10.3201/eid2407.170721] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
28 Bamberger EE, Ben-Shimol S, Abu Raya B, Katz A, Givon-Lavi N, Dagan R, Srugo I; Israeli Pediatric Bacteremia and Meningitis Group. Pediatric invasive Haemophilus influenzae infections in Israel in the era of Haemophilus influenzae type b vaccine: a nationwide prospective study. Pediatr Infect Dis J 2014;33:477-81. [PMID: 24445822 DOI: 10.1097/INF.0000000000000193] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
29 Kotler L, Greenberg D, Givon-Lavi N, van der Beek BA, Dagan R, Ben-Shimol S. Decline in pneumococcal nasopharyngeal carriage in children 6-23 months with respiratory illnesses following pneumococcal conjugate vaccine implementation. Vaccine 2021;39:5757-61. [PMID: 34481698 DOI: 10.1016/j.vaccine.2021.08.082] [Reference Citation Analysis]
30 Ceyhan M, Ozsurekci Y, Gürler N, Öksüz L, Aydemir S, Ozkan S, Yuksekkaya S, Keser Emiroglu M, Gültekin M, Yaman A, Kiremitci A, Yanık K, Karli A, Ozcinar H, Aydin F, Bayramoglu G, Zer Y, Gulay Z, Gayyurhan ED, Gül M, Özakın C, Güdücüoğlu H, Perçin D, Akpolat N, Ozturk C, Camcıoğlu Y, Karadağ Öncel E, Çelik M, Şanal L, Uslu H. Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014. Hum Vaccin Immunother 2016;12:308-13. [PMID: 26325175 DOI: 10.1080/21645515.2015.1078952] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
31 Ben-shimol S, Givon-lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media. Clin Infect Dis 2016;63:611-8. [DOI: 10.1093/cid/ciw347] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 10.8] [Reference Citation Analysis]
32 Shen CF, Wang SM, Chi H, Huang YC, Huang LM, Huang YC, Lin HC, Ho YH, Hsiung CA, Liu CC; Taiwan Pediatric Infectious Disease Alliance. The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia. J Biomed Sci 2020;27:88. [PMID: 32814590 DOI: 10.1186/s12929-020-00680-9] [Reference Citation Analysis]
33 Greenberg D, Givon-Lavi N, Ben-Shimol S, Ziv JB, Dagan R. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years. Vaccine 2015;33:4623-9. [PMID: 26116251 DOI: 10.1016/j.vaccine.2015.06.062] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 9.9] [Reference Citation Analysis]
34 Butsashvili M, Kandelaki G, Eloshvili M, Chlikadze R, Imnadze P, Avaliani N. Surveillance of bacterial meningitis in the country of Georgia, 2006-2010. J Community Health 2013;38:724-6. [PMID: 23475302 DOI: 10.1007/s10900-013-9670-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
35 Regev-yochay G, Paran Y, Bishara J, Oren I, Chowers M, Tziba Y, Istomin V, Weinberger M, Miron D, Temper V, Rahav G, Dagan R. Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study. Vaccine 2015;33:1135-42. [DOI: 10.1016/j.vaccine.2015.01.030] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
36 Dagan R, Ben-Shimol S, Greenberg D, Givon-Lavi N. A Prospective, Population-based Study to Determine the Incidence and Bacteriology of Bacterial Conjunctivitis in Children <2 Years of Age Following 7-Valent and 13-Valent Pneumococcal Conjugate Vaccine Sequential Implementation. Clin Infect Dis 2021;72:1200-7. [PMID: 32140705 DOI: 10.1093/cid/ciaa197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Bar-Lev S, Reichman S, Barnett-Itzhaki Z. Prediction of vaccine hesitancy based on social media traffic among Israeli parents using machine learning strategies. Isr J Health Policy Res 2021;10:49. [PMID: 34425894 DOI: 10.1186/s13584-021-00486-6] [Reference Citation Analysis]
38 Kenig A, Regev-Yochay G, Khakshoor S, Cohen-Poradosu R, Bishara J, Glikman D, Hershman-Sarafov M, Dagan R, Zimhony O; IAIPD Research Group. Hospital-onset adult invasive pneumococcal disease in Israel: Sicker patients, different pathogens. Int J Infect Dis 2019;85:195-202. [PMID: 31226404 DOI: 10.1016/j.ijid.2019.06.013] [Reference Citation Analysis]
39 Marom T, Tshori S, Shefer G, Pitaro J. Pneumococcal Conjugated Vaccines Decreased Acute Otitis Media Burden: A Population-Based Study in Israel. J Pediatr 2021;235:233-238.e3. [PMID: 33894263 DOI: 10.1016/j.jpeds.2021.04.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kasher M, Roizin H, Cohen A, Jaber H, Mikhailov S, Rubin C, Doron D, Rahav G, Regev-yochay G. The impact of PCV7/13 on the distribution of carried pneumococcal serotypes and on pilus prevalence; 14 years of repeated cross-sectional surveillance. Vaccine 2020;38:3591-9. [DOI: 10.1016/j.vaccine.2020.03.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Ben-Shimol S, Givon-Lavi N, Greenberg D, Stein M, Megged O, Bar-Yochai A, Negari S, Dagan R, On Behalf Of The Israel Bacteremia And Meningitis Active Surveillance Group. Impact of pneumococcal conjugate vaccines introduction on antibiotic resistance of Streptococcus pneumoniae meningitis in children aged 5 years or younger, Israel, 2004 to 2016. Euro Surveill 2018;23. [PMID: 30482264 DOI: 10.2807/1560-7917.ES.2018.23.47.1800081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
42 Ngo CC, Massa HM, Thornton RB, Cripps AW. Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review. PLoS One 2016;11:e0150949. [PMID: 26953891 DOI: 10.1371/journal.pone.0150949] [Cited by in Crossref: 98] [Cited by in F6Publishing: 85] [Article Influence: 16.3] [Reference Citation Analysis]
43 Ribitzky-eisner H, Minuhin Y, Greenberg D, Greenberg N, Chodick G, Craiu M, Leibovitz E. Epidemiologic and Microbiologic Characteristics of Occult Bacteremia Among Febrile Children in Southern Israel, Before and After Initiation of the Routine Antipneumococcal Immunization (2005–2012). Pediatrics & Neonatology 2016;57:378-84. [DOI: 10.1016/j.pedneo.2015.10.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
44 Hoen B, Varon E, de Debroucker T, Fantin B, Grimprel E, Wolff M, Duval X. Management of acute community-acquired bacterial meningitis (excluding newborns). Long version with arguments. Médecine et Maladies Infectieuses 2019;49:405-41. [DOI: 10.1016/j.medmal.2019.03.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
45 Ben-Shimol S, Givon-Lavi N, Grisaru-Soen G, Megged O, Greenberg D, Dagan R; Israel Bacteremia and Meningitis Active Surveillance Group. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies. Vaccine 2018;36:5477-84. [PMID: 28579230 DOI: 10.1016/j.vaccine.2017.05.059] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
46 Levy C, Varon E, Picard C, Béchet S, Martinot A, Bonacorsi S, Cohen R. Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France. Pediatr Infect Dis J 2014;33:1216-21. [PMID: 25037044 DOI: 10.1097/INF.0000000000000451] [Cited by in Crossref: 47] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
47 Ben-Shimol S, Givon-Lavi N, Kotler L, Adriaan van der Beek B, Greenberg D, Dagan R. Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines. Emerg Infect Dis 2021;27:150-60. [PMID: 33350916 DOI: 10.3201/eid2701.201178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Regev-Yochay G, Rahav G, Riesenberg K, Wiener-Well Y, Strahilevitz J, Stein M, Glikman D, Weber G, Potasman I, Dagan R; IAIPD study group. Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in Israel. PLoS One 2014;9:e88406. [PMID: 24516649 DOI: 10.1371/journal.pone.0088406] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
49 Ben-Shimol S, Givon-Lavi N, Greenberg D, Dagan R. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel. Hum Vaccin Immunother 2016;12:268-76. [PMID: 26430921 DOI: 10.1080/21645515.2015.1095414] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
50 Stein-Zamir C, Rishpon S. The National Immunization Technical Advisory Group in Israel. Isr J Health Policy Res 2021;10:7. [PMID: 33499907 DOI: 10.1186/s13584-021-00442-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Regev-Yochay G, Rahav G, Strahilevitz J, Bishara J, Katzir M, Chowers M, Finkelstein R, Chazan B, Zimhony O, Dagan R; IAIPD study group. A nationwide surveillance of invasive pneumococcal disease in adults in Israel before an expected effect of PCV7. Vaccine 2013;31:2387-94. [PMID: 23518404 DOI: 10.1016/j.vaccine.2013.02.059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
52 Ludwig G, Garcia-Garcia S, Lanaspa M, Ciruela P, Esteva C, Fernandez de Sevilla M, Diaz-Conradi A, Marti C, Motje M, Galles C, Morta M, Izquierdo C, Moraga-Llop F, Campins M, Salleras L, Jane M, Dominguez A, Garcia-Garcia JJ, Muñoz-Almagro C; Catalan Study Group of Invasive Pneumococcal Disease. Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain. PLoS One 2020;15:e0228612. [PMID: 32027715 DOI: 10.1371/journal.pone.0228612] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
53 Su WJ, Lo HY, Chang CH, Chang LY, Chiu CH, Lee PI, Lu CY, Hsieh YC, Lai MS, Lin TY. Effectiveness of Pneumococcal Conjugate Vaccines of Different Valences Against Invasive Pneumococcal Disease Among Children in Taiwan: A Nationwide Study. Pediatr Infect Dis J 2016;35:e124-33. [PMID: 26974752 DOI: 10.1097/INF.0000000000001054] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
54 Wang MC, Wang YP, Chu CH, Tu TY, Shiao AS, Chou P. Impact of pneumococcal conjugate vaccine on pediatric tympanostomy tube insertion in partial immunized population. ScientificWorldJournal 2015;2015:248678. [PMID: 25839052 DOI: 10.1155/2015/248678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Regev-Yochay G, Katzir M, Strahilevitz J, Rahav G, Finn T, Miron D, Maor Y, Chazan B, Schindler Y, Dagan R; IAIPD group. The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel. Vaccine 2017;35:2449-56. [PMID: 28342668 DOI: 10.1016/j.vaccine.2017.03.031] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
56 Yun KW, Choi EH, Lee HJ, Kang JH, Kim KH, Kim DS, Kim YJ, Eun BW, Oh SH, Cho HK, Hong YJ, Kim KN, Kim NH, Kim YK, Lee H, Lee T, Kim HM, Cho EY, Kim CS, Park SE, Oh CE, Jo DS, Choi YY, Lee J. Genetic structures of invasive Streptococcus pneumoniae isolates from Korean children obtained between 1995 and 2013. BMC Infect Dis 2018;18:268. [PMID: 29884115 DOI: 10.1186/s12879-018-3177-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
57 Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Miron D, Aviner S, Dagan R; Israel Bacteremia and Meningitis Active Surveillance Group. Impact of PCV7/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD. Vaccine 2016;34:4543-50. [PMID: 27475471 DOI: 10.1016/j.vaccine.2016.07.038] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]